MedPath

Prime physiological determinants associated with peak power and endurance cycling performance

Completed
Conditions
geen aandoeningen
-
Registration Number
NL-OMON42016
Lead Sponsor
Vrije Universiteit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Male, age 18-45 year
Trained track or road cyclists (VO2-max > 55ml/kg/min)
Low risk / healthy: based on the outcome of the anamnesis form

Exclusion Criteria

Allergic to local anesthetic
Female
Age < 18 or > 45 year
VO2-max < 55 ml/kg/min
Risk: based on the outcome of the anamnesis form

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome of this study is the peak power and endurance cycling<br /><br>performance of the cyclist (POpeak during Wingate and VO2-max). These two<br /><br>outcome measures will be related to muscle contractile characteristics (i.e.<br /><br>mitochondrial density, myoglobin concentration, capillary density, muscle fiber<br /><br>size and fiber type).</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath